Tevaquel XL 200 mg Prolonged-release tablets
Authorisation PA0749/060/007 · Teva Pharma B.V.
- Licence holder
- Teva Pharma B.V. (all products →)
- Active substance
- Quetiapine
- Clinical trials
- 10 clinical trials →
- Dosage form
- Prolonged-release tablet
- Route of administration
- Oral use
- ATC code
- N05AH04
- First authorised
- 13/04/2012
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Generic application (Article 10(1) of Directive No 2001/83/EC)
Quetiapine: supply and approvals
63 authorised products on the HPRA list contain Quetiapine. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 21 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 21 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 21 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 14 years (since 13 April 2012). The HPRA list marks it as marketed in Ireland.
Other medicines with Quetiapine in Ireland
54 other products on the HPRA list contain Quetiapine, from 10 licence holders; 39 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Notiabolfen XL 200 mg prolonged-release Tablet | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| Quentiax SR 200 mg prolonged-release tablets | KRKA, d.d., Novo mesto | National authorisation (PA) | Marketed |
| Quentiax SR 50 mg prolonged-release tablets | KRKA, d.d., Novo mesto | National authorisation (PA) | Marketed |
| Quetex 100 mg film-coated tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| Quetex 200 mg film-coated tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| Quetex 25mg film-Coated tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| Quetex 300 mg film-coated tablets | Rowex Ltd | National authorisation (PA) | Marketed |
| Quetex XR 200 mg prolonged-release tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| Quetex XR 300 mg prolonged-release tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| Quetex XR 400 mg prolonged-release tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| Quetex XR 50 mg prolonged-release tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| Quetiapine 100 mg film-coated tablets | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
The licence holder
Teva Pharma B.V. holds 155 products on the HPRA list, with 69 different active substances; 100 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 22 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.